Rationale for development of platinum analogs. | Cancer Treat Rep;63(9-10): 1493-8, 1979. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Rationale for development of platinum analogs.

Burchenal, J H; Kalaher, K; Dew, K; Lokys, L.

Cancer Treat Rep ; 63(9-10): 1493-8, 1979.

Article in En | MEDLINE | ID: mdl-498148

Subject(s)

Cisplatin/therapeutic use; Leukemia, Experimental/drug therapy; Animals; Cisplatin/administration & dosage; Cisplatin/analogs & derivatives; Cyclohexylamines/therapeutic use; Drug Evaluation, Preclinical; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Mice; Organoplatinum Compounds/therapeutic use; Thiourea/administration & dosage

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Experimental / Cisplatin Limits: Animals Language: En Journal: Cancer Treat Rep Year: 1979 Document type: Article Country of publication: United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Experimental / Cisplatin Limits: Animals Language: En Journal: Cancer Treat Rep Year: 1979 Document type: Article Country of publication: United States